Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × camrelizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 5 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Nasopharyngeal Carcinoma 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Pancreatic Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Biliary Tract Carcinoma 1

Interventions

Carboplatin 19 durvalumab 18 Etoposide 18 atezolizumab 17 PM 01183 10 Topotecan 8 pembrolizumab 6 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Drug Therapy 5 Paclitaxel 4 Bevacizumab 4 AMG 757 4 anlotinib 3 amrubicin 3 Temozolomide 3 Radiotherapy 3 Platinum 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Cisplatin 3 tremelimumab 2 toripalimab 2 sacituzumab govitecan 2 olaparib 2 monalizumab 2 enzalutamide 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡